Ivan Formentini
Novo Nordisk (Denmark)(DK)
Publications by Year
Research Areas
Chronic Kidney Disease and Diabetes, Renal Diseases and Glomerulopathies, Pancreatic function and diabetes, Telomeres, Telomerase, and Senescence, Protein Kinase Regulation and GTPase Signaling
Most-Cited Works
- → Tissue transcriptome-driven identification of epidermal growth factor as a chronic kidney disease biomarker(2015)424 cited
- → Regulation of PKD by the MAPK p38δ in Insulin Secretion and Glucose Homeostasis(2009)243 cited
- → ERK1 and ERK2 mitogen-activated protein kinases affect Ras-dependent cell signaling differentially(2006)208 cited
- → Growth Differentiation Factor–15 and Risk of CKD Progression(2017)181 cited
- → Telomerase expression confers cardioprotection in the adult mouse heart after acute myocardial infarction(2014)162 cited
- → Telomerase gene therapy rescues telomere length, bone marrow aplasia, and survival in mice with aplastic anemia(2016)106 cited
- → Comparison of Plasma and Urine Biomarker Performance in Acute Kidney Injury(2015)94 cited
- → The BAR Domain Protein Arfaptin-1 Controls Secretory Granule Biogenesis at the trans-Golgi Network(2012)92 cited
- → Spatial Transcriptional Mapping Reveals Site-Specific Pathways Underlying Human Atherosclerotic Plaque Rupture(2023)88 cited
- → The N-Terminal Domain of ERK1 Accounts for the Functional Differences with ERK2(2008)59 cited